Knight Cancer in the News
The OHSU Knight Cancer Institute’s work to end cancer as we know it receives international, regional and local media coverage. Here are selected highlights of the Knight Cancer Institute in the news.
OHSU completes $1 billion Knight Cancer Challenge June 2015
The OHSU Knight Cancer Institute announced that it has met the $1 billion Knight Cancer Challenge, issued in September 2013 by Phil and Penny Knight. The money will go toward advancing research to fight cancer at its earliest stages and detect the disease before it spreads.
As featured in:
- ABC News - Good Morning America
- Portland Business Journal
- Portland Business Journal
- OregonLive
- Statesman Journal
- KOIN
- Bloomberg Business
- KPTV
- KATU
- Portland Tribune
- Chronicle of Philanthropy
- Portland Business Journal
- KGW
- Footwear News
- GoLocalPDX
- Washington Times
- OPB
- Portland Tribune
- Fortune
- Portland Business Journal
- Portland Business Journal
- American Association for the Advancement of Science
- KXL
- TechTimes
- Portland Business Journal
- CNBC
- Nature
- The Sporting News
- Inside Philanthropy
- Portland Tribune
- 24/7 Sports
Team climbs Mount Hood to raise money for Knight Cancer Challenge June 2015
Team climbs Mount Hood to raise money for Knight Cancer Challenge June 2015
A team of nine climbers recently raised more than $11,000 for the Knight Cancer Challenge by scaling Mount Hood.
As featured in: 
OHSU renames research building for biochemist Hildegard Lamfrom June 2015
OHSU renamed its Biomedical Research Building in honor of biochemist Hildegard Lamfrom, whose sister Gert Boyle donated $100 million to the Knight Cancer Challenge fundraising campaign. Lamfrom, who worked in top laboratories alongside numerous research pioneers, died of brain cancer in 1984.
As featured in: 
OHSU skin cancer event draws hundreds May 2015
OHSU hosted a Skin Cancer Research Expo and Sun Safety Event to learn more about melanoma and help prepare attendees for a sunny summer. Attendees were given the chance to take part in ongoing research, get free skin checks and join the Melanoma Community Registry.
As featured in: 
Knight Cancer researcher receives grant to unlock liver-breast cancer puzzle May 2015
Pepper Schedin, Ph.D., a breast cancer researcher with the OHSU Knight Cancer Institute, was awarded a one-year grant from the OHSU Center for Women’s Health Circle of Giving. Schedin will study the size of women’s livers during and after pregnancy and its possible connection to breast cancer deaths.
As featured in: 
OHSU strives to cut Oregon’s melanoma diagnoses in half May 2015
Sancy Leachman, M.D., Ph.D., director of the Melanoma Research Program at the OHSU Knight Cancer Institute, launched in May 2014 the Melanoma Community Registry, a tool she hopes will help cut the number of Oregon’s higher-than-average melanoma diagnoses in half. Central Oregon residents are at a higher risk than other residents in the state, due in part to the nearly 300 sunny days they experience each year.
As featured in: 
OHSU and Columbia Memorial Hospital expand treatment services May 2015
The OHSU Knight Cancer Institute and Columbia Memorial Hospital are developing a new 18,000-square-foot cancer treatment center and specialty clinic in Astoria, Oregon. The center will expand Columbia Memorial’s existing chemotherapy treatment services and bring radiation therapy services to the North Coast.
As featured in: 
Cambia employees donate $1 million to Knight Cancer Challenge May 2015
Cambia Health Foundation and Cambia Health Solutions employees donated $1 million to the Knight Cancer Challenge. The donation was made possible by a weeklong employee campaign in April, with 2:1 matching support from the foundation.
As featured in:
OHSU and Intel work to decode the roots of cancer April 2015
Two years after starting a collaboration, OHSU and Intel are on the brink of scaling their work to capture data from patients across the United States and creating a “collaborative cancer cloud.”
As featured in:
Firefighters raise $21,000 for Knight Cancer Challenge March 2015
Firefighters from throughout Oregon raised $21,000 for the Knight Cancer Challenge. The Oregon State Fire Fighters Council spearheaded the effort and received contributions from firefighters from 18 local unions throughout the state.
As featured in: 
Druker appears in new Ken Burns cancer documentary March 2015
Brian Druker, M.D., director of the OHSU Knight Cancer Institute, was interviewed about his breakthrough research that led to the drug Gleevec in the latest multi-part documentary from Ken Burns, “Emperor of All Maladies”. Druker’s research proved that targeted drugs, such as Gleevec, could transform how cancer is treated.
As featured in: 
Knight Cancer patients discuss CML, Gleevec and their cancer journeys March 2015
OPB’s Think Out Loud spoke with two patients of Brian Druker, M.D., director of the OHSU Knight Cancer Institute, whose research was featured in the latest Ken Burns documentary “Emperor of All Maladies”. Judy Orem and Doug Jenson spoke about the impact of the drug Gleevec, the product of Druker’s breakthrough research. They also talked about their chronic myeloid leukemia diagnoses and how they are doing today.
As featured in: 
Clinical trial testing polio injections just one potential tool to fight cancer March 2015
Prakash Ambady, M.D., spoke with KGW for a story about a Duke University clinical trial in which researchers are injecting a modified form of the polio virus into a glioblastoma brain tumor . Ambady said that researchers are continually looking for new ways to treat cancer, including treatments that enable immune cells to find and attack cancer cells.
As featured in:
OHSU Knight Cancer Institute oncologists scale Mount Kilimanjaro March 2015
Charles Blanke, M.D., chair of SWOG and an oncologist with the OHSU Knight Cancer Institute, and Brett Sheppard, M.D., F.A.C.S., director of the OHSU Knight Cancer Institute’s pancreatic cancer program, climbed Mount Kilimanjaro, the tallest peak in Africa, in February 2015. Afterward, Blanke wrote about the experience.
As featured in: 
Memorial bench presented to OHSU Knight Cancer Institute March 2015
A new memorial bench honoring the late wife of a Beaverton police officer was recently dedicated at the OHSU Knight Cancer Institute in Beaverton. Kendall Rowe received chemotherapy at the institute but died of colon cancer in 2013. Her husband said he hopes the bench will be uplifting to other patients.
As featured in: 
Oregon grant seeks to make cancer tests accessible March 2015
A handful of groups in Oregon that help individuals with disabilities live independently are working together on a project that will make cancer screening tests more accessible. The project, aided by a grant from the OHSU Knight Cancer Institute, will train peer support specialists to ask about screening and stress their importance.
As featured in:
OHSU Knight Cancer Institute recruits star specialist February 2015
Raymond Bergan, M.D., was recently appointed associate director of medical oncology for the OHSU Knight Cancer Institute. Bergan, formerly of Northwestern University, is an internationally regarded specialist known for breakthrough research into understanding how early stage cancer cells spread.
As featured in: 
Leachman speaks at Women’s Health Day event February 2015
Sancy Leachman, M.D., Ph.D., director of the OHSU Knight Cancer Institute’s Melanoma Research Program and chair of the OHSU Department of Dermatology, spoke at the 2015 Women’s Health Day event in Bandon, Oregon. The day’s theme focused on cancer, and Leachman spoke about the importance of melanoma research and care.
As featured in: 
$100-million Oregon donor flaunts her tough-mother reputation February 2015
Columbia Sportswear Chairman Gert Boyle, known throughout the Pacific Northwest as “one tough mother,” makes one of the largest philanthropic gifts of the year when she donated $100 million to the OHSU Knight Cancer Institute.
As featured in: 
World Cancer Day recognized around the world February 2015
World Cancer Day’s focus in 2015 was on, among other things early detection. The OHSU Knight Cancer Institute shares that focus. It seeks to transform cancer detection with an ambitious research program.
As featured in: 
Earlier detection needed to take chance out of cancer survival February 2015
Ed McLaughlin thought he was in the best shape of his life when he was diagnosed with chronic myeloid leukemia. His cancer was caught by chance. The OHSU Knight Cancer Institute seeks to improve early cancer detection to ensure the disease is caught when it’s most treatable.
As featured in: 
Need that genome sequenced? OHSU can now do it in a day January 2015
Thanks to a grant of more than $900,000 from the M.J. Murdock Charitable Trust, OHSU has greatly increased the speed at which it can sequence DNA. The equipment was recently installed in the lab of OHSU Knight Cancer Institute researcher Paul Spellman, Ph.D. , and is part of a larger effort to improve DNA analysis.
As featured in:
OHSU doctors to climb Kilimanjaro for cancer research January 2015
Charles Blanke, M.D., and Brett Sheppard, M.D., F.A.C.S., will climb Mount Kilimanjaro in February 2015 to raise money for cancer clinical trials and oncology research.
In a related a story about clinical trials and how they’re funded, a Knight Cancer Institute patient discussed her OHSU experience and the clinical trial she took part in.
As featured in:
OHSU doctor discusses genomics and the field’s impact on cancer research January 2015
Christopher Corless, M.D., Ph.D., appeared on the OPB Radio program Think Out Loud to discuss genomics, how genetic data is used to personalized medicine and how technology has changed what we know about cancer.
As featured in:
Druker, Leachman named ‘people to watch in health care’ December 2014
Brian Druker, M.D., and Sancy Leachman, M.D., Ph.,D., were named to the Portland Business Journal’s list of eight people to watch in Oregon health care in 2015.
As featured in:
Breast cancer researcher receives $100,000 grant to develop postnatal pill December 2014
Pepper Schedin, Ph.D., a breast cancer researcher with the OHSU Knight Cancer Institute recently received a $100,000 grant from the Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and the V Foundation for Cancer Research. With the funding, Schedin will be able to investigate the impact of anti-inflammatory drugs, such as ibuprofen or aspirin, on the unique biology of women’s bodies post-pregnancy.
As featured in: 
FEI, OHSU expand their partnership for high-powered microscopes December 2014
FEI Co., the Hillsboro, Ore.-based maker of electronic microscopes, expanded its partnership with OHSU and the OHSU Knight Cancer Institute. This expansion adds a new instrument, the FEI CorrSightTM, to the OHSU-FEI correlative light and electron microscopy suite, in the Living Lab for Cell Biology. This agreement that includes the installation of a complete correlative microscopy workflow that will help researchers better understand how cancer cells and other diseases develop in the body.
As featured in:
Sen. Wyden: Oregon on the leading edge in palliative
care November 2014
U.S. Sen. Ron Wyden, in a keynote speech at the American Cancer Society Cancer Action Network’s forum on palliative care, said that Oregon is leading the way when it comes to palliative care. Along with Wyden, speakers at the event included Erik Fromme, M.D., M.C.R., FAAHPM, medical director of OHSU Palliative Service,and Susan Hedlund, M.S.W., L.C.S.W., O.S.W.-C, manager of patient and family support servicesfor the OHSU Knight Cancer Institute. Fromme and Hedlund shared their views on misconceptions surrounding and the importance of palliative care.
As featured in:
The Ford Family Foundation donates $5 million to Knight Cancer Challenge for rural outreach November 2014
The Ford Family Foundation has given $5 million to the OHSU Knight Cancer Institute, which counts toward the Knight Cancer Challenge, to expand prevention and care programs for rural Oregonians.
As featured in:
Brian Druker among five American winners of prestigious Hamdan Medical Award November 2014
Brian Druker, M.D., director of the OHSU Knight Cancer Institute, won the Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Research Excellence. Druker won the award for his breakthrough work on targeted cancer therapies, which produced a paradigm shift in the treatment of cancer.
As featured in: 
Breast cancer inspires local musician to put on fundraising concert November 2014
Jenny Conlee, keyboard player for the Decemberists, was diagnosed with breast cancer in 2011 at the age of 38. That experience led her to put on a yearly event called Notes of Hope, which is aimed at cancer patients between the ages of 15 and 39. The event, which includes a mix of live music and storytelling, benefits the OHSU Knight Cancer Institute’s Adolescent and Young Adult Oncology Program.
As featured in: 
Standard employees wear jeans, raise big bucks for
cancer November 2014
Standard Insurance Co., through its 2014 Employee Giving Campaign, raised $534,000 for the Knight Cancer Challenge. More than 1,500 current and retired employees donated, exceeding expectations and more than doubling the original pledge amount.
As featured in:
OHSU doctor hopes melanoma registry will aid education, research November 2014
Doctors and patients gathered recently at OHSU for a conference on melanoma, to cover cutting-edge treatments for this deadly disease led by Sancy Leachman, M.D., director, OHSU Knight Cancer Institute Melanoma Program and chair, Department of Dermatology. Members of the Melanoma Community Registry, launched in May 2014 by the OHSU Knight Cancer Institute, gathered recently to learn about the disease, new treatments and research results. More than 3,000 patients, family members and friends have signed up for the registry to date.
As featured in:
Portland filmmaker explores healing through humor November 2014
Portland film student Ben Schorr’s documentary about how humor can help in coping with cancer features interviews with three people who share different perspectives, including Brian Druker, M.D., director of the OHSU Knight Cancer Institute. Schorr’s mother participated in Dr. Druker’s clinical trials that made Gleevec®, the first targeted cancer drug of its kind, a reality for patients.
As featured in:
OHSU scientist finds exercise stops or slows bone loss for cancer survivors November 2014
Kerri Winters-Stone, Ph.D., a researcher at the OHSU Knight Cancer Institute, studies the benefits of exercise and how it might help people cope with the aftermath of cancer treatment. Winters-Stone discussed what exercise could mean for cancer survivors.
As featured in:
Oregon business groups, unions team up to raise funds for Knight Cancer Challenge September 2014
Seven Oregon business and labor organizations have teamed up to form Unite for the Knight, a coalition to build support and raise money for the $1 billion Knight Cancer Challenge.
As featured in: 
High Desert conditions lead to high skin cancer rates September 2014
Oregon’s sunny High Desert region boasts some of the highest rates of skin cancer in the state. Sancy Leachman, M.D., Ph.D., head of melanoma research at the OHSU Knight Cancer Institute, weighed in on the conditions that lead to such high skin cancer rates and discusses which symptoms to watch for.
As featured in: 
Aptose Biosciences joins OHSU to fight deadly form of leukemia September 2014
Aptose Biosciences joined the Beat AML collaboration, led by researchers at the OHSU Knight Cancer Institute. The multi-institutional research initiative aims to find treatments for acute myeloid leukemia (AML).
As featured in: 
Brian Druker joins Live Wire September 2014
OHSU Knight Cancer Institute Director Brian Druker, M.D., joined the season premiere of Live Wire, a Portland-based radio show that airs nationally. The show focused on trailblazers in their fields. Druker’s interview focused on his research that led to the once-a-day cancer pill Gleevec® and the plans he has to meet what he believes is most important unmet need in cancer care today.
As featured in: 
'Your Voice, Your Vote:' Gert Boyle and her donation September 2014
Gert Boyle, the chairwoman of Columbia Sportswear, discussed her $100 million donation to the OHSU Knight Cancer Institute with KATU.
As featured in:
FDA expands use of prostate cancer pill because of clinical trials led at Knight Cancer Institute September 2014
Enzalutamide received federal approval based on OHSU Knight Cancer Institute clinical study showing it prolongs life, enables prostate cancer patients to delay chemotherapy.
As featured in: 
Men, if you’re 50, it’s time for a prostate exam August 2014
Christopher Amling, M.D., urologic cancer specialist with the OHSU Knight Cancer Institute, discussed the importance of prostate exams, the pros and cons of the screening and when to have a conversation about the exam with a physician.
As featured in: 
Columbia Sportswear chairwoman revealed as $100-million donor August 2014
The OHSU Knight Cancer Institute received in July 2014 a $100-million gift from Gert Boyle, the chairwoman of Columbia Sportswear. She initially made the donation anonymously but later publicly confirmed her identity to encourage others to give.
As featured in: (1) (2) (1) (2) (3)
BioCentury: transformative medicine August 2014
Brian Druker, M.D., director of the OHSU Knight Cancer Institute, explained the science behind Gleevec and other targeted cancer drugs, which moved treatment from systemic and toxic therapies to life-saving approaches with specific targets.
As featured in: 
Anonymous $100 million gift moves OHSU within $82 million of reaching $1 billion goal August 2014
The OHSU Knight Cancer Institute moved one step closer to meeting a spectacular fundraising goal when it received a $100 million gift from an anonymous donor.
As featured in:
When unapproved drugs are the only hope August 2014
Nathalie Traller was diagnosed in 2013 with a rare cancer that a new class of drugs may help combat. But, at 15 years old, she’s too young to qualify for the related clinical trials. Brian Druker, M.D., director of the OHSU Knight Cancer Institute and a major force behind development of the leukemia drug Gleevec, has adopted Nathalie’s case and is working with colleagues at the National Institutes of Health to explore possible options for her.
As featured in: 
$100-Million gift pushes Oregon University to brink of securing $500-million match July 2014
Oregon Health & Science University received a $100-million anonymous gift, which became part of a $1 billion fundraising drive for the Knight Cancer Institute that got a large dose of urgency from Phil and Penny Knight’s pledge.
As featured in:
OHSU receives $100 million anonymous gift toward Knight Cancer Challenge July 2014
An anonymous donor gave $100 million to OHSU Knight Cancer Institute to help a fundraising challenge <link to www.onedown.org> ; the gift is one of the four largest pledges in OHSU’s history and is the largest private donation to the campaign to date.
As featured in:
Pete Julian's race isn't over, but the Oregon Project coach is kicking cancer July 2014
Pete Julian, now an assistant coach with the Nike Oregon Project distance runners training group, was at a loss following his 2008 cancer surgery. Diagnosed with GIST, his third gastrointestinal surgery was only partially successful, leaving him with at least three tumors. When Dr. Michael Heinrich put him on a targeted therapy that OHSU’s Brian Druker helped develop, his tumors vanished.
As featured in:
Private science July 2014
Private donors are playing an increasingly important role in the funding—and direction—of scientific research including at the OHSU Knight Cancer Institute.
As featured in: 
How OHSU's Brian Druker hopes to cure cancer January 2014
Brian Druker, M.D., director of OHSU’s Knight Cancer Institute, and OHSU President Joe Robertson, M.D., M.B.A., share insights on OHSU’s $200 million request for state support, the $1 billion Knight Cancer Challenge, and what OHSU will do with the billion dollars it is raising.
As featured in: 
Can cancer be cured in the Northwest? July 2014
Between Oregon Health & Science University’s Knight Cancer Institute, the University of Washington School of Medicine, and the Fred Hutchinson Cancer Research Center, the Pacific Northwest is becoming a cancer research hotbed.
As featured in:
Growing participation in Novartis' Signature Program bodes well for novel PGx signal finding approach July 2014
Drug maker Novartis last year launched the Signature Program, a drug trial series in which patients are enrolled in mutation-specific study protocols that emphasize molecular pathways over tumor sites or histology. Oregon Health & Science University is among the institutions leading the program.
As featured in: 
(Article available only to Genome Web subscribers)
OHSU's Knight Cancer Challenge bites off a $1M pledge June 2014
Willamette Dental Group announced in June 2014 that it will contribute $1 million to the Knight Cancer Challenge. The group dental practice will match all contributions to the challenge in the next year, and then President and Chief Executive Officer Dr. Eugene Skourtes will match the combined total.
As featured in:
“Be the Match” search for a bone marrow transplant June 2014
Cynthia Speckman, who was treated at the OHSU Knight Cancer Institute for chronic myeloid leukemia (CML ) appeared on KATU’s AM Northwest to talk about her diagnosis and search for a bone marrow transplant. She was joined by Be the Match spokesperson Kim Allen, who spoke about the organization and its efforts to help patients get marrow or cord blood transplants.
As featured in:
Local employees join Knight Cancer Challenge June 2014
Oregon companies have provided a huge boost to the $1 billion Knight Cancer Challenge since its announcement in September 2013. The Standard launched a year-long employee campaign in June 2014 to lend its support, vowing to raise more than $250,000 for the OHSU Knight Cancer Institute.
As featured in:
OHSU's Druker spells out plans for early cancer detection team June 2014
Brian Druker, M.D., director of the OHSU Knight Cancer Institute, told employees of The Standard that revolutionizing early cancer detection will be an integral part of Knight Cancer’s mission going forward. Druker was invited to speak to employees of The Standard as the company launched a campaign to raise funds for the $1 billion Knight Cancer Challenge.
As featured in:
FDA: Tanning lamps now considered 'high-risk' May 2014
In an effort to reduce rising rates of skin cancer linked to tanning devices, the FDA announced that tanning beds and sun lamps must carry new warnings. The OHSU Knight Cancer Institute increased its advocacy for such restrictions in 2013 when it, among other things, campaigned in support of Oregon passing a law restricting minors’ access to tanning beds.
As featured in:
OHSU doctor wages war on melanoma in Oregon May 2014
Sancy Leachman, M.D., Ph.D., who leads melanoma research at OHSU Knight Cancer Institute, recently launched a registry to create a network for advancing the treatment, prevention and detection of the disease.
As featured in:
Oregon's clouds no protection against melanoma: Guest opinion May 2014
An OHSU patient discusses his experiences with melanoma and promotes the new Community Melanoma Registry, set up by the OHSU Knight Cancer Institute, in a guest column penned for The Oregonian.
As featured in:
OHSU reports $86 million in private donations for cancer research March 2014
Donors have given Oregon Health & Science University’s Knight Cancer Institute about $86 million within six months toward a $500 million goal. When combined with $200 million in bonding approved by state lawmakers, the institute is well past the halfway mark in meeting a $500 million challenge from Nike co-founder Phil Knight. More than 3,700 donations and pledges came from 47 states; Washington, D.C.; and Canada.
As featured in: (1) (2) 
Cancer research for dogs could help children March 2014
A Knight Cancer Institute doctor is looking for dogs with cancer for his research on treatment that could benefit children with bone cancer.
As featured in:
Who are the biggest givers? And where do they get the money? February 2014
Big philanthropy returned in 2013, keyed in part by Nike co-founder Phil Knight and his wife Penelope Knight. The Knights kick started the Knight Cancer Challenge with a $500 million pledge, provided OHSU can raise matching funds within two years.
As featured in:
Video - How OHSU's Brian Druker hopes to cure cancer January 2014
Watch a video of Dr. Brian Druker at Willamette Week, discussing the opportunity to cure cancer with a $1.2 billion investment from private philanthropy as part of the Knight Cancer Challenge and state infrastructure support.
As featured in: 
Drug shows promise in advanced prostate cancer when used before chemotherapy January 2014
The New York Times reports on potential broader use of Xtandi to treat prostate cancer following clinical trial conducted at the Knight Cancer Institute.
As featured in: 
Drug may extend survival for men with advanced prostate cancer January 2014
A recently released study suggests that a new hormone therapy may increase survival for men with advanced prostate cancer. HealthDay speaks with the Knight Cancer Institute’s deputy director, Tomasz Beer, M.D. about the implications for patients.
As featured in: 
OHSU's Knight Cancer Challenge to create more than 1K jobs, inject millions January 2014
The Portland Business Journal reports on how investing in cancer research will yield thousands of jobs, millions into local and state economy and help create a cancer-curing economy for Oregon.
As featured in:
Editorial: Knight gift to OHSU is worth more state money January 2014
The Daily Astorian weighs in with why the Knight gift to OHSU is worth more state money
As featured in:
Q&A: Why OHSU wants $200 million from Oregon Legislature for cancer research January 2014
A Q&A with an Oregonian capitol reporter explains how Oregon can support transformational cancer research and clinical trials as part of the Knight Cancer Challenge.
As featured in:
Approve OHSU bonds: Oregon has a big stake in cancer institute January 2014
Read why the Eugene Register Guard supports the state providing capital bonding support for cancer research and patient care.
As featured in: 
How OHSU's Brian Druker Hopes to Cure Cancer January 2014
OHSU President Joe Robertson and Dr. Brian Druker sit in Willamette Week’s “Hot Seat” and answer questions about the Knight Cancer Challenge and Oregon’s opportunity to end cancer as we know it.
As featured in:
Oregon could sell $200 million in bonds for Phil and Penny Knight's $1 billion challenge for OHSU cancer research November 2013
Building on a record of success in partnerships, the Oregonian reports on $200 million in capital construction bonding OHSU is requesting for critical infrastructure to support cancer research and patient care/clinical trials.
As featured in:
A challenge to energize Oregon November 2013
Tim Nesbitt, a columnist for The Oregonian, shares how the $1 billion Knight Cancer Challenge is an opportunity to take pride in the ingenuity of our scientists and the generosity of Oregonians.
As featured in:
Medivation cancer drug improves survival in wider use trial October 2013
Reuters details results of a prostate cancer drug clinical trial, led by Knight Cancer Institute Deputy Director.
As featured in: 
Who gives? October 2013
The Knight Cancer Challenge is unprecedented for any fundraising campaign. It has the potential to transform philanthropy in Oregon and around the world.
As featured in:
Editorial
Billion dollar Knight Cancer challenge September 2013
Dr. Brian Druker, talks about a billion research dollars.
As featured in:
$1 billion hanging in the balance, Knight Cancer Institute must show its best September 2013
An Oregonian editorial on the Knight Cancer Challenge.
As featured in:
$500M pledge September 2013
Phil and Penny Knight pledge $500 million, if OHSU can match it.
As featured in: 
Learn more about OHSU Knight Cancer Institute from these sources:
Smithsonian on Brian Druker, M.D., director of the OHSU Knight Cancer Institute
New York Times on Brian Druker’s stance on cancer drug prices
New England Journal of Medicine documentary on Brian Druker’s impact on cancer research and treatment
Wall Street Journal review of book that chronicles the history of Brian Druker’s cancer research breakthrough
Wall Street Journal on Beat AML collaboration
Wall Street Journal on program for young adults with cancer
Portland Monthly on the OHSU Knight Cancer Institute’s cancer research vision
Intel Corporation’s president’s speech including segment on OHSU-Intel collaboration in cancer research
The Oregonian on prostate cancer Dream Team
The Oregonian on breast cancer researcher Lisa Coussens
New York Times and Joe Gray
The Oregonian on the OHSU Knight Cancer Institute’s strategic vision
The Oregonian on the Knight Diagnostic Laboratories
Healthy Body, Healthy Mind on PBS, Treatment of Chronic Myeloid Leukemia
Healthy Body, Healthy Mind on PBS, Treatment of Gastrointestinal Stromal Tumor